Genestack
PrivateLast Round
Grant
Feb 1, 2016
Total Funding Raised
$130,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genestack operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in February 2016.
Genestack is a life sciences informatics company that provides a multi-omics data management and integration software platform to pharmaceutical, agriscience, and consumer goods organizations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Data Integration, Drug Discovery, Data Governance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genestack Comparables
Compare Genestack with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siemens | 79% | |
| LatchBio | 79% | |
| Collate | 77% |
For institutional investors. Book with your work email.
Genestack Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2016 | ||||
| Seed | Jul 10, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genestack Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 67% MoM, reaching 2.3K.
- Dec 4, 2025
Monthly visitors grew 1028% MoM, from 112 to 1.3K.
For institutional investors. Book with your work email.
Genestack Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genestack's valuation, stock price, and market status.
Is Genestack a public or private company?
Genestack is a private company.
What is the current stock price of Genestack?
Genestack is a private company, so its shares have no public market price. Caplight tracks Genestack's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genestack worth (valuation)?
Valuation information for Genestack is not publicly available.
Can I buy Genestack stock?
Genestack shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genestack's last funding round?
Genestack's most recent funding round was Grant on February 1, 2016.
Who are the main investors in Genestack?
Key investors in Genestack include Innovate UK.
Will Genestack IPO soon?
No public IPO plans have been announced for Genestack.
How can I track Genestack secondary market activity?
Caplight tracks bids, offers, and trades in Genestack's shares on secondary markets.